OTC Indies: U.S. Analysis of Independent OTC Companies
|出版商||Kline & Company, Inc.||商品編碼||917244|
|出版日期||內容資訊||英文 380 Pages
|美國的獨立型OTC企業分析 OTC Indies: U.S. Analysis of Independent OTC Companies|
|出版日期: 2019年04月19日||內容資訊: 英文 380 Pages||
With the recent low growth of traditional OTCs, many large market players will seek growth via acquisition of complementary companies and/or brands. This study offers in-depth profiles of approximately 70 independent OTC companies, many of which have recently recorded double-digit sales growth. These companies often outpace market growth by offering unique brands, unique and often natural ingredients, focused distribution, and a strong online presence, frequently combined with compelling digital marketing that resonates with today's OTC consumers. This report identifies these market disruptors and assess the factors that make them resonate with consumers and retailers.
This report helps subscribers to:
‘OTC Indies: U.S. Analysis of Independent OTC Companies’ is an appraisal of about 70 independent OTC companies that have disrupted categories and grown at rates greater than the industry average.
This report provides insights and information on the most compelling independent OTC companies and brands that are helping to shape the OTC market. While some of these brands and companies are small in terms of sales volume now, they have resonated with consumers and are poised for growth.
This report provides:
Regional Coverage: United States.
Profiles of approximately 70 OTC companies (see Table 1), with each including the following: